Position in GILD
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$3,897,336
-$447,802 QoQ
Shares Held
30,848
-1.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.05%
of 13F equity value
Holder Rank
#166
of 913 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026VALLEY NATIONAL ADVISERS INC holds $26,573,081 across 16 Drug Manufacturers - General names. GILD ranks #3 (14.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,036 | $6,040,329 | |
| 2 | MRK |
Merck & Co., Inc.
|
44,957 | $5,776,974 | |
| 3 | GILD |
Gilead Sciences, Inc.
This page
|
30,848 | $3,897,336 | |
| 4 | AMGN |
Amgen Inc
|
10,266 | $3,717,523 | |
| 5 | AZN |
Astrazeneca PLC
|
13,217 | $2,506,207 | |
| 6 | ABBV |
AbbVie Inc.
|
5,759 | $1,449,194 | |
| 7 | NVS |
Novartis AG
|
7,794 | $1,221,475 | |
| 8 | JNJ |
Johnson & Johnson
|
3,962 | $1,006,229 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,897,336 | 30,848 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $4,345,138 | 31,177 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $3,937,499 | 32,080 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $3,632,142 | 32,722 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $3,697,847 | 33,353 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $3,954,244 | 35,290 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $3,518,650 | 38,093 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $3,953,474 | 47,155 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $6,233,492 | 90,854 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $7,173,884 | 97,937 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $8,231,668 | 101,613 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $8,069,988 | 107,686 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $8,814,803 | 114,374 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $10,053,806 | 121,174 | Shares | Sole | 2023-04-26 | |
| 2022-12-31 | $10,578,093 | 123,216 | Shares | Sole | 2023-01-12 | |
| 2022-09-30 | $7,741,046 | 125,483 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $7,603,742 | 123,018 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $6,741,273 | 113,394 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $5,388,242 | 74,208 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $4,350,397 | 62,282 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $3,708,937 | 53,862 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $2,530,652 | 39,156 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $74,689 | 1,282 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $82,652 | 1,308 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $100,637 | 1,308 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $92,179 | 1,233 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||